Sek M. Su

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: August 11, 2025

Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.

Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.

Journal: Cell death & disease

Published: February 02, 2025

BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.

BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.

Journal: Cancer research

Published: October 27, 2022

Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.

Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.

Journal: Theranostics

Published: June 17, 2021

S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.

S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.

Journal: Nature communications

Published: March 15, 2021

ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.

ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.

Journal: The Journal of clinical investigation

Published: March 10, 2021

Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.

Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.

Journal: Theranostics

Published: February 18, 2021

Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor.

Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor.

Journal: Nature communications

Published: December 03, 2019

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Journal: Nature communications

Published: November 04, 2019

In vivo Mouse Mammary Gland Formation.

In vivo Mouse Mammary Gland Formation.

Journal: Bio-protocol

Published: September 17, 2019

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

Journal: Nature communications

Published: June 11, 2019

Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice.

Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice.

Journal: The Journal of biological chemistry

Published: October 30, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026